The prognostic impact of plasma methylated HOXA9 in patients with advanced non-small cell lung cancer.

被引：0
|
作者：
Christensen, Sara Witting
Hansen, Torben
Nyhus, Christa Haugaard
Hager, Henrik
Hilberg, Ole
Andersen, Rikke Fredslund
Jakobsen, Anders Kristian Moeller
机构：
[1] Vejle Hosp, Dept Oncol, Vejle, Denmark
[2] Univ Southern Denmark, Inst Reg Hlth Res, Vejle Hosp, Dept Oncol, Vejle, Denmark
[3] Vejle Hosp, Dept Clin Pathol, Vejle, Denmark
[4] Vejle Hosp, Dept Internal Med, Vejle, Denmark
[5] Vejle Hosp, Dept Clin Biochem, Vejle, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24063
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The prognostic impact of circulating homeobox A9 methylated DNA in advanced non-small cell lung cancer
    Wen, Sara Witting Christensen
    Andersen, Rikke Fredslund
    Hansen, Torben Frostrup
    Nyhus, Christa Haugaard
    Hager, Henrik
    Hilberg, Ole
    Jakobsen, Anders
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (02) : 855 - +
  • [2] NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
    Wen, Sara Witting Christensen
    Nederby, Line
    Andersen, Rikke Fredslund
    Hansen, Torben Schjodt
    Nyhus, Christa Haugaard
    Hilberg, Ole
    Jakobsen, Anders
    Hansen, Torben Frostrup
    BRITISH JOURNAL OF CANCER, 2023, 129 (01) : 135 - 142
  • [3] Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer
    Madoka Kimura
    Tateaki Naito
    Hirotsugu Kenmotsu
    Tetsuhiko Taira
    Kazushige Wakuda
    Takuya Oyakawa
    Yasushi Hisamatsu
    Takaaki Tokito
    Hisao Imai
    Hiroaki Akamatsu
    Akira Ono
    Kyoichi Kaira
    Haruyasu Murakami
    Masahiro Endo
    Keita Mori
    Toshiaki Takahashi
    Nobuyuki Yamamoto
    Supportive Care in Cancer, 2015, 23 : 1699 - 1708
  • [4] Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer
    Kimura, Madoka
    Naito, Tateaki
    Kenmotsu, Hirotsugu
    Taira, Tetsuhiko
    Wakuda, Kazushige
    Oyakawa, Takuya
    Hisamatsu, Yasushi
    Tokito, Takaaki
    Imai, Hisao
    Akamatsu, Hiroaki
    Ono, Akira
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Mori, Keita
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    SUPPORTIVE CARE IN CANCER, 2015, 23 (06) : 1699 - 1708
  • [5] NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
    Sara Witting Christensen Wen
    Line Nederby
    Rikke Fredslund Andersen
    Torben Schjødt Hansen
    Christa Haugaard Nyhus
    Ole Hilberg
    Anders Jakobsen
    Torben Frøstrup Hansen
    British Journal of Cancer, 2023, 129 : 135 - 142
  • [6] Advanced non-small cell lung cancer.
    Edelman M.J.
    Khanwani S.L.
    Current Treatment Options in Oncology, 2001, 2 (1) : 51 - 62
  • [7] HOXA9 inhibits migration of lung cancer cells and its hypermethylation is associated with recurrence in non-small cell lung cancer
    Hwang, Jung-Ah
    Lee, Bo Bin
    Kim, Yujin
    Hong, Seung-Hyun
    Kim, Young-Ho
    Han, Joungho
    Shim, Young Mog
    Yoon, Chae-Yeong
    Lee, Yeon-Su
    Kim, Duk-Hwan
    MOLECULAR CARCINOGENESIS, 2015, 54 : E72 - E80
  • [8] NK cell activity and methylated HOXA9 circulating tumor DNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
    Wen, Sara Witting Christensen
    Nederby, Line
    Andersen, Rikke Fredslund
    Hansen, Torben Schjoedt
    Haugaard, Christa
    Hilberg, Ole
    Jakobsen, Anders
    Hansen, Torben
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Circadian function of patients with advanced non-small cell lung cancer.
    Levin, RD
    Grutsch, JF
    Hrushesky, WJM
    Quiton, J
    Quinn, K
    Daehler, M
    Lis, CG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 693S - 693S
  • [10] Outcome of elderly patients with advanced non-small cell lung cancer.
    Gumus, M
    Palak, B
    Iyikesici, S
    Yumuk, PF
    Seker, M
    Topal, A
    Dane, F
    Salepci, T
    Yayla, A
    Turhal, NS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 706S - 706S
12345